T/CACM 1369-2021 Active Group standards

T/CACM 1369-2021 Clinical Diagnosis and Treatment Guidelines for Polycythemia Vera in Plateau Areas Based on Traditional Chinese Medicine

T/CACM 1369-2021

Publish Date: 2021-07-16 Implement Date: 2021-07-16 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 1369-2021
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2021-07-16
Implement Date: 2021-07-16

Scope

Main technical content: 1 Scope 2 Normative reference documents 3 Terms and definitions 4 Epidemiological characteristics and pathogenesis 4.1 Incidences and risk factors 4.2 Etiology and pathogenesis 4.3 Traditional Chinese Medicine (TCM) etiology and pathogenesis 5 Clinical manifestations 5.1 Symptoms 5.2 Signs 5.3 Auxiliary examinations 6 Diagnosis 6.1 Western medical diagnostic criteria 6.2 Exclusion criteria 7 TCM syndrome differentiation 7.1 Qi deficiency and blood stasis 7.2 Qi and Yin deficiency 7.3 Qi stagnation and blood stasis 7.4 Phlegm-dampness obstructing the lungs 7.5 Qi and blood deficiency 8 TCM treatment principles and recommended regimens 8.1 Treatment principles 8.2 Differentiated treatment based on syndrome differentiation 8.3 Traditional Chinese medicine preparations 9. Other therapies 10. Main outcome indicators 10.1 Main outcome indicators 10.2 Health economic evaluation 10.3 Adverse reactions and safety evaluation Appendix A (Normative) Plateau Polycythemia Scoring Method Appendix B (Normative) Evidence Quality and Recommendation Grading References

Development Information

Related Standards

Contact Us